AACE Annual Meeting
Thyroid
Kaniksha Desai, MD, ECNU, FACE
Assistant Professor
Stanford University School of Medicine, California, United States
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
.jpg "Sarimar Agosto, MD photo")
Sarimar Agosto, MD
Oncologic Endocrinologist, Assistant Professor
Moffitt Cancer Center
Disclosure: Blueprint Medicine (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); EISAI (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- October 2021); Lilly Oncology (Self) : Local Site PI of Clinical Trial from Lilly Oncology (Status: Terminated --- August 2021), Research Support (Status: Terminated --- August 2021)
Peter M. Sadow, MD, PhD
Director, Head & Neck Pathology
Massachusetts General Hospital
Boston, Massachusetts, United States
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michael Yeh, MD
Professor of Surgery and Medicine
UCLA David Geffen School of Medicine
Los Angeles, California, United States
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mimi Hu, MD
Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Disclosure: Blueprint Medicines (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/01/2020); Eli Lilly (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Contracted Research (Status: Ongoing); Targeted Oncology (Self) : Honorarium (Status: Terminated --- 12/16/2020), Speaker for Educational Program (Status: Terminated --- 12/16/2020); Veracyte (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 3/28/2020)